iShares Global Healthcare ETF

IXJ · ETF

$109.40−$0.95 (−0.86%)TodayMarket closed ·
Prev close $110.35

About IXJ

IXJ was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 4384.33m in AUM and 111 holdings. IXJ tracks a market-cap-weighted index of global health care companies.

Issuer
iShares
Tracks
S&P Global 1200 Health Care Sector Capped Index - USD - Benchmark TR Net
Expense ratio
0.38%
Assets under management
$4.49B
Inception
Nov 13, 2001
Asset class
Equity

IXJ key statistics

Market cap
0
Price-earnings ratio
0.00
Average volume
217.15K
Volume
114.80K
Open price
$109.77
High today
$109.77
Low today
$108.93
52 Week high
$110.78
52 Week low
$90.28

iShares Global Healthcare ETF (IXJ) at a glance

iShares Global Healthcare ETF (IXJ) last traded at $109.40, with a market cap of 0 and a price-to-earnings ratio of 0.00.

Today the fund has traded between $108.93 and $109.77. The current price is 0.4% above the day's low and 0.3% below its high.

Volume so far is 114.80K shares, below the average of 217.15K shares a day.

Over the past year iShares Global Healthcare ETF has ranged from $90.28 to $110.78, and now sits 93% of the way up that range.

IXJ news

  • Vandana Singh

    White House Reportedly Preparing To Oust FDA Commissioner Marty Makary

  • Vandana Singh

    Eli Lilly Jumps As Earnings Beat Meets FDA Tightening Drug Compounding Rules

  • Mohd Haider

    Trump Admin Targets Medicaid Spending On Immigrants, Threatening Over $12 Billion California Program

  • Vandana Singh

    World Health Organization Responds to Trump's Order, Reminds Decades of Successful Health Achievements

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.